Treatments of the hematological manifestation in Fanconi anemia (FA) is first supportive with attempts to stimulate hematopoiesis with androgens or hematopoietic growth factors.
Introduction
Fanconi anemia (FA) is a severe bone marrow (BM) failure syndrome affecting children at an early age. Somatic cell fusion studies resulted in the classification of FA patients into 11 complementation groups, each corresponding to a separate gene 1 . Nine of these disease genes have been cloned, FANCA, FANCB, FANCC, FANCD1/BRCA2, FANCD2, FANCE, FANCF and FANCG and FANCL/PHF9 [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . Although no specific molecular function has been attributed to their gene products, FA proteins participate in a complex involved in maintaining genomic integrity [12] [13] [14] [15] [16] [17] .
The clinical manifestation of FA is defined by a progressive bone marrow failure and in the majority of cases, a multitude of congenital malformations and an increased risk of developing cancers 18, 19 . Short-term treatments include the administration of androgens and hematopoietic growth factors 20-23 which may transiently improve peripheral blood counts.
However, studies using the Fancc mouse model have shown that long-term administration of growth factors did not prevent eventual bone marrow failure and may even accelerate bone marrow hypoplasia 24 . The long-term curative treatment of the hematological manifestation of the disease is BM or peripheral blood stem cell transplantation. This procedure offers a significant chance of cure if a sibling HLA-matched donor is available 25, 26 , but carries a substantial risk with HLA-matched unrelated BM donors 27 . An alternative curative treatment for those patients with no sibling donors might be gene transfer into hematopoietic stem cells. Stem and progenitor cells can easily be harvested from the bone marrow or peripheral blood and transduced ex vivo using viral vectors as a delivery system. In view of their self-renewal capacity, corrected stem cells, in theory, could replenish the hematopoietic compartment and sustain long-term Prior to analysis, propidium iodine (PI; Sigma) was added at a final concentration of 50 ng/ml in order to detect apoptotic nuclei. Cells were visualized by fluorescence microscopy using an inverted fluorescence microscope (Nikon TE300; Nikon Canada) equipped with a CCD camera (Hamamastu, Orca ER; Nikon Canada). Percent PI positive cells were estimated from 100 to 500 cells in 2 separate experiments.
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-stem cells were able to divide and differentiate, these cells showed twice more apoptosis during culture than wild-type stem cells ( Figure 6 ).
Discussion
Different combinations of cytokines have been tested in order to support ex vivo expansion of hematopoietic stem cells. In our experiments, we used a combination of SCF, FL and TPO which is generally accepted as promoting growth of primitive hematopoietic cells [34] [35] [36] and, in fact, did promote growth and maintenance of wild-type hematopoietic stem cells.
However, using the same culture condition, Fancc 
